Eversept Partners, LP

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1697013 NEW YORK, NY

Position in PTGX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$7,171,420

+$2,545,807 QoQ

Shares Held

58,504

+10.5% QoQ

Ownership

0.090%

of shares outstanding

% of Portfolio

0.39%

of 13F equity value

Holder Rank

#83

of 341 holders

Holding Since

Jun 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Eversept Partners, LP holds $859,319,346 across 72 Biotechnology names. PTGX ranks #29 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	913,880	$121,783,648
2	VERA	Vera Therapeutics, Inc.	2,212,770	$94,949,960
3	CLDX	Celldex Therapeutics, Inc.	1,785,941	$66,454,864
4	SNDX	Syndax Pharmaceuticals Inc	2,798,210	$61,168,870
5	IONS	Ionis Pharmaceuticals Inc	664,684	$52,702,794
6	TVTX	Travere Therapeutics, Inc.	798,973	$45,389,656
7	PCVX	Vaxcyte, Inc.	629,952	$36,619,109
8	GERN	Geron Corp	18,717,422	$23,958,300

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,171,420	58,504	+10.5%	Shares	Sole	2026-08-14
2025-12-31	$4,625,613	52,961	-80.9%	Shares	Sole	2026-02-17
2025-06-30	$15,327,255	277,316	-49.3%	Shares	Sole	2025-08-14
2025-03-31	$26,458,529	547,116	-19.4%	Shares	Sole	2025-05-15
2024-12-31	$26,201,178	678,787	+52.5%	Shares	Sole	2025-02-14
2024-09-30	$20,034,180	445,204	-12.0%	Shares	Sole	2024-11-14
2024-06-30	$17,527,217	505,836	+22.9%	Shares	Sole	2024-08-14
2024-03-31	$11,904,058	411,478	-23.5%	Shares	Sole	2024-05-15
2023-12-31	$12,338,036	538,074	+87.6%	Shares	Sole	2024-02-14
2023-09-30	$4,782,956	286,748	+150.1%	Shares	Sole	2023-11-14
2023-06-30	$3,166,881	114,659	—	Shares	Sole	2023-11-08
No filing history on record for this holder in this stock.